JUNIPER PHARMACEUTICALS INC·4

Apr 13, 6:06 AM ET

JUNIPER PHARMACEUTICALS INC 4

4 · JUNIPER PHARMACEUTICALS INC · Filed Apr 13, 2017

Insider Transaction Report

Form 4
Period: 2017-04-11
Patel Nikin
DirectorCEO, Molecular Profiles
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2017-04-11+10,00010,000 total
    Exercise: $4.05Exp: 2024-04-11Common Stock, $0.01 par value per share (10,000 underlying)
Footnotes (1)
  • [F1]The option will be exercisable in 25% increments of the shares on each annual anniversary of the date of the grant.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION